11/14/2019  8:02:36 AM Chg. -0.0660 Volume Bid2:18:34 PM Ask2:18:34 PM Market Capitalization Dividend Y. P/E Ratio
0.4260EUR -13.41% 0
Turnover: 0.0000
0.4610Bid Size: 4,566 0.4920Ask Size: 4,269 14.12 mill.EUR 0.00% -

Business description

aap Implantate AG is a globally operating medical device company headquartered in Berlin, Germany. The company develops, manufactures and markets trauma products for orthopedics. The IP protected portfolio includes besides the innovative anatomical plating system LOQTEQ® and trauma complementary biomaterials a wide range of cannulated screws as well as standard plates and screws. Furthermore, aap Implantate AG has an innovation pipeline with promising development projects as the antibacterial silver coating technology and magnesium based implants. These technologies address critical problems in surgery that haven’t yet been resolved adequately. In German-speaking Europe aap Implantate AG directly sells its products to hospitals, buying syndicates and hospital groups while it has a broad network of distributors in more than 20 countries at the international level.
 

Management board & Supervisory board

CEO
Rubino Di Girolamo
Management board
Marek Hahn
Supervisory board
Dr. Nathalie Krebs, Biense Visser, Jacqueline Rijsdijk
 

Company data

Name: aap Implantate AG
Address: Lorenzweg 5,D-12099 Berlin
Phone: +49-30-75019-0
Fax: +49-30-75019-111
E-mail: mail@aap.de
Internet: www.aap.de/
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 42.77%
IPO date: 5/10/1999

Investor relations

Name: Fabian Franke
IR phone: +49-30-75019-134
IR Fax: +49-30-75019-290
IR e-mail: -

Company calendar

CW 46 | 11/14/2019 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
42.77%
Ratio Capital Management B.V.
 
16.26%
Noes Beheer B.V.
 
13.57%
Jürgen W. Krebs
 
9.96%
Taaleri Arvo Rein Osake
 
5.00%
Deepblue Holding AG
 
4.86%
Elocin B.V.
 
4.60%
Baring Asset Management Limited
 
2.98%
Others
 
0.00%